Ocugen, Inc.
DE ˙ DB ˙ US67577C1053
1,15 € ↑0,02 (2,13%)
2026-06-05
DEL PRIS
SecurityDE:2H51 / Ocugen, Inc.
InstitutionMillennium Management Llc
ManagerIsrael Englander
Latest Disclosed Ownership17,074,584 shares
Ownership 5.20%
Millennium Management Llc ownership in 2H51 / Ocugen, Inc.

2026-04-14 - Millennium Management Llc has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 17,074,584 shares of Ocugen, Inc. (DE:2H51). This represents 5.2 percent ownership of the company.

Millennium Management Llc has a history of taking positions in derivatives of the underlying security (2H51) in the form of stock options. The firm currently holds call options representing 205,000 of underlying shares valued at $371,050 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File
Date
Effective
Date
Form Prev
Shares
Latest
Shares
ΔShares
(Percent)
Ownership
(Percent)
ΔOwnership
(Percent)
2026-04-14 2026-04-14 13G 17,074,584 5.20

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:2H51 / Ocugen, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F OCUGEN COM 67577C105 13,727,192 8,330,775 154.38 24,846 241.06 0.0103
2026-02-17 2025-12-31 13F OCUGEN COM 67577C105 5,396,417 1,234,268 29.65 7,285 7.39 0.0031
2025-11-14 2025-09-30 13F OCUGEN COM 67577C105 4,162,149 -896,777 -17.73 6,784 38.20 0.0029
2025-08-14 2025-06-30 13F OCUGEN COM 67577C105 5,058,926 4,977,618 6,121.93 4,909 8,512.28 0.0024
2025-05-15 2025-03-31 13F OCUGEN COM 67577C105 81,308 -90,064 -52.55 57 -58.39 0.0000
2025-02-14 2024-12-31 13F OCUGEN COM 67577C105 171,372 171,372 138 0.0001
2024-08-14 2024-06-30 13F OCUGEN COM 67577C105 0 -1,925,755 -100.00 0 -100.00
2024-05-15 2024-03-31 13F OCUGEN COM 67577C105 1,925,755 1,514,792 368.60 3,158 1,238.14 0.0013
2024-02-14 2023-12-31 13F OCUGEN COM 67577C105 410,963 -1,213,366 -74.70 236 -63.64 0.0001
2023-11-14 2023-09-30 13F OCUGEN COM 67577C105 1,624,329 -1,392,208 -46.15 650 -60.38 0.0003
2023-08-14 2023-06-30 13F OCUGEN COM 67577C105 3,016,537 1,748,855 137.96 1,638 51.53 0.0008
2023-05-15 2023-03-31 13F OCUGEN COM 67577C105 1,267,682 1,267,682 1,081 0.0006
2023-02-14 2022-12-31 13F OCUGEN COM 67577C105 0 -249,878 -100.00 0 -100.00
2022-11-14 2022-09-30 13F OCUGEN COM 67577C105 249,878 94,820 61.15 445 26.42 0.0003
2022-08-15 2022-06-30 13F OCUGEN COM 67577C105 155,058 155,058 352 0.0002
2022-05-16 2022-03-31 13F OCUGEN COM 67577C105 0 -459,168 -100.00 0 -100.00
2022-02-14 2021-12-31 13F OCUGEN COM 67577C105 459,168 437,923 2,061.30 2,089 1,265.36 0.0011
2021-11-15 2021-09-30 13F OCUGEN COM 67577C105 21,245 -510,074 -96.00 153 -96.41 0.0001
2021-08-16 2021-06-30 13F OCUGEN COM 67577C105 531,319 222,500 72.05 4,266 103.43 0.0026
2021-05-17 2021-03-31 13F OCUGEN COM 67577C105 308,819 308,819 -41.88 2,097 -50.84 0.0015
2019-11-14 2019-09-30 13F HISTOGENICS COM 43358V109 0 -98,161 -100.00 0 -100.00
2019-08-15 2019-06-30 13F/A-1 HISTOGENICS COM 43358V109 98,161 87,118 788.90 19 1,800.00 0.0000
2019-08-14 2019-06-30 13F TRINSEO S A SHS 43358V109 103,315 92,272 4,374
2019-05-14 2019-03-31 13F HISTOGENICS COM 43358V109 11,043 -138,344 -92.61 1 -92.31 0.0000
2019-02-15 2018-12-31 13F/A-1 HISTOGENICS COM 43358V109 149,387 149,387 1,252.78 13 1,200.00 0.0000
2019-02-14 2018-12-31 13F HISTOGENICS COM 43358V109 149,387 13
2015-11-16 2015-09-30 13F HISTOGENICS COM 43358V109 0 -19,254 -100.00 0 -100.00
2015-08-14 2015-06-30 13F HISTOGENICS COM 43358V109 19,254 -11,676 -37.75 124 -59.87 0.0002
2015-05-15 2015-03-31 13F HISTOGENICS COM 43358V109 30,930 930 3.10 309 -6.36 0.0006
2015-02-17 2014-12-31 13F HISTOGENICS COM 43358V109 30,000 30,000 330 0.0007
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F OCUGEN COM Call 205,000 371 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.